It's time we measure more than Australia's gastrectomy mortality rate

Mary Ann Johnson^{1

2

3}, Nicole Winter^{1

2}, Mark Smithers^{4

5

6}

Affiliations

¹ Department of Surgery, St Vincent's Hospital Melbourne, Fitzroy, Australia.
² Department of Surgery, Royal Melbourne Hospital, Parkville, Australia.
³ Department of Surgery, Eastern Health, Box Hill, Australia.
⁴ Faculty of Medicine, University of Queensland, Woolloongabba, Queensland, Australia.
⁵ Cancer Alliance Queensland, Woolloongabba, Queensland, Australia.
⁶ Upper Gastrointestinal, Soft Tissue and Melanoma Unit, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.

Editorial

Mary Ann Johnson et al. ANZ J Surg. 2022 Sep.

. 2022 Sep;92(9):1972-1973.

doi: 10.1111/ans.17997.

Mary Ann Johnson^{1

2

3}, Nicole Winter^{1

2}, Mark Smithers^{4

5

6}

¹ Department of Surgery, St Vincent's Hospital Melbourne, Fitzroy, Australia.
² Department of Surgery, Royal Melbourne Hospital, Parkville, Australia.
³ Department of Surgery, Eastern Health, Box Hill, Australia.
⁴ Faculty of Medicine, University of Queensland, Woolloongabba, Queensland, Australia.
⁵ Cancer Alliance Queensland, Woolloongabba, Queensland, Australia.
⁶ Upper Gastrointestinal, Soft Tissue and Melanoma Unit, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.

No abstract available

Comment on

Gastrectomy mortality in Australia.
Davis SS, Noll D, Patel P, Maloney RT, Maddern GJ. Davis SS, et al. ANZ J Surg. 2022 Sep;92(9):2109-2114. doi: 10.1111/ans.17540. Epub 2022 Feb 18. ANZ J Surg. 2022. PMID: 35180327

1. Davis SS, Noll D, Patel P, Maloney RT, Maddern GJ. Gastrectomy mortality in Australia. ANZ J. Surg. 2022; 92: 2109-2114.
1. Tian K, Baade PD, Aitken JF, Narendra A, Smithers BM. Procedure-specific outcomes following gastrectomy for cancer compared by hospital volume and service capability. ANZ J. Surg. 2021; 91: 2430-5.
1. Rajabiyazdi F, Alam R, Pal A et al. Understanding the meaning of recovery to patients undergoing abdominal surgery. JAMA Surg. 2021; 156: 758-65.
1. Aloia TA, Zimmitti G, Conrad C, Gottumukalla V, Kopetz S, Vauthey JN. Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy. J. Surg. Oncol. 2014; 110: 107-14.
1. Finnerty DT, Buggy DJ. Return to intended oncologic therapy: a potentially valuable endpoint for perioperative research in cancer patients? Br. J. Anaesth. 2020 May; 124: 508-10.